Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2015, Article ID 243298, 14 pages
http://dx.doi.org/10.1155/2015/243298
Review Article

Potential Therapeutic Targets in Uterine Sarcomas

1Department of Oncology, Gynaecologic Oncology, KU Leuven (University of Leuven), 3000 Leuven, Belgium
2Department of Obstetrics and Gynaecology, University Hospitals Leuven, 3000 Leuven, Belgium
3Center for Gynaecologic Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek-Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands

Received 14 August 2015; Accepted 30 September 2015

Academic Editor: Silvia Stacchiotti

Copyright © 2015 Tine Cuppens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Kuo-Chang Wen, Huann-Cheng Horng, Peng-Hui Wang, Yi-Jen Chen, Ming-Shyen Yen, and Heung-Tat Ng, “Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review,” Taiwanese Journal of Obstetrics and Gynecology, vol. 55, no. 4, pp. 463–471, 2016. View at Publisher · View at Google Scholar
  • Huann-Cheng Horng, Kuo-Chang Wen, Peng-Hui Wang, Yi-Jen Chen, Ming-Shyen Yen, and Heung-Tat Ng, “Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review,” Taiwanese Journal of Obstetrics and Gynecology, vol. 55, no. 4, pp. 472–479, 2016. View at Publisher · View at Google Scholar
  • Birgit Rommel, Carsten Holzmann, and Jörn Bullerdiek, “Malignant mesenchymal tumors of the uterus – time to advocate a genetic classification,” Expert Review of Anticancer Therapy, vol. 16, no. 11, pp. 1155–1166, 2016. View at Publisher · View at Google Scholar
  • Ming-Shyen Yen, Jen-Ruei Chen, Peng-Hui Wang, Kuo-Chang Wen, Yi-Jen Chen, and Heung-Tat Ng, “Uterine sarcoma part III—Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review,” Taiwanese Journal of Obstetrics and Gynecology, vol. 55, no. 5, pp. 625–634, 2016. View at Publisher · View at Google Scholar
  • Rr Cui, Jd Wright, and Jy Hou, “Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome,” BJOG: An International Journal of Obstetrics & Gynaecology, 2017. View at Publisher · View at Google Scholar
  • Michal Zikan, Jutta Huvila, Olli Carpen, Johannes Haybaeck, Farid Moinfar, Maciej Stukan, Carole Mestdagh, Daniela Annibali, Leonardus F. Massuger, Michael R. Mallmann, Miriam Mints, Debby Thomas, Els Hermans, Frederic Amant, Jone Trovik, Natalja Te rHaar, Tine Cuppens, Mariel Brinkhuis, Pavel Dundr, Helga B. Salvesen, Ronald P. Zweemer, Eva Wardelmann, Godelieve Verbist, Ellen Gomme, Philippe Moerman, An Coosemans, Tjalling Bosse, Eva Colas, Angel Garcia-Jimenez, Koen Van De Vijver, and Roy P.M. Kruitwagen, “Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas - An ENITEC Group Initiative,” Clinical Cancer Research, vol. 23, no. 5, pp. 1274–1285, 2017. View at Publisher · View at Google Scholar
  • Stephanie Ricci, Rebecca L. Stone, and Amanda N. Fader, “Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation,” Gynecologic Oncology, 2017. View at Publisher · View at Google Scholar
  • Lien Hoang, Sarah Chiang, and Cheng-Han Lee, “Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations,” Pathology, 2017. View at Publisher · View at Google Scholar
  • Mi Kyoung Kim, Taek Sang Lee, Jae-Weon Kim, Jong-Min Lee, Beob Jong Kim, and Seok Ju Seong, “Management of Leimyosarcoma,” International Journal of Gynecological Cancer, vol. 27, no. 9, pp. 1912–1918, 2017. View at Publisher · View at Google Scholar
  • Tamas Korcsmaros, Maria Victoria Schneider, and Giulio Superti-Furga, “Next generation of network medicine: interdisciplinary signaling approaches,” Integr. Biol., 2017. View at Publisher · View at Google Scholar
  • Zhiwei Qiao, Takashi Tajima, Fusako Kito, Yasuhito Arai, Akira Kawai, and Tadashi Kondo, “Metastasis-associated gene signature in primary myxoid liposarcoma identified through a gene expression study,” Journal of Electrophoresis, vol. 61, no. 1, pp. 9–15, 2017. View at Publisher · View at Google Scholar
  • Kun Hooi Leng, Gwee Sing Wei, Dinesh Kumar Chellappan, Jestin Chellian, Gaurav Gupta, Lee Jia Jia, Tiong Ying, Kamal Dua, Wong Chun Hoong, Yap Cheng Qian, Nur Amirah Binti Abdul Aziz, and Fam Yi Ling, “The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review,” Biomedicine and Pharmacotherapy, vol. 102, pp. 1127–1144, 2018. View at Publisher · View at Google Scholar
  • Anne Kaul, Alexander Mustea, Matthias B. Stope, Victor Cernat, Karoline Diesing, Dominique Koensgen, and Martin Burchardt, “Functionality of the Tumor Suppressor microRNA-1 in malignant tissue and cell line cells of uterine leiomyosarcoma,” Anticancer Research, vol. 38, no. 3, pp. 1547–1550, 2018. View at Publisher · View at Google Scholar